Nymox Pharmaceutical Corporation (NYMX): Price and Financial Metrics
Nymox Pharmaceutical Corporation (NYMX)
Today's Latest Price: $1.83 USD
Updated Oct 22 8:00pm
Add NYMX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
NYMX Stock Price Chart More Charts
NYMX Price/Volume Stats
| Current price | $1.83 |
| Prev. close | $1.85 |
| Day low | $1.80 |
| Day high | $1.90 |
| 50-day MA | $1.84 |
| 200-day MA | $1.88 |
| 52-week high | $2.75 |
| 52-week low | $1.25 |
| Volume | 29,100 |
| Avg. volume | 98,590 |
| Dividend yield | N/A |
| Market Cap | 123.85M |
Nymox Pharmaceutical Corporation (NYMX) Company Bio
Nymox Pharmaceutical Corporation engages in the research and development of drugs for the aging population. It markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. The company also offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimers disease. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in Phase III clinical trials for the treatment of enlarged prostate or benign prostatic hyperplasia, as well as is in Phase II clinical trial for low grade localized prostate cancer. The company was founded in 1989 and is based in Nassau, The Bahamas.
Top Stories View All
Best & Worst Performing Stock Industries for October 22, 2019
Best & Worst Performing Small Cap Stocks for October 22, 2019
Best & Worst Performing Mid Cap Stocks for October 22, 2019
Best & Worst Performing Large Cap Stocks for October 22, 2019
Best & Worst Performing Mega Cap Stocks for October 22, 2019
View All Top Stories
Loading social stream, please wait...